U.S. company’s vaccine shows highly promising results against U.K. variant and lower, but “still pretty good” efficacy with South Africa strain. Source
U.S. company’s vaccine shows highly promising results against U.K. variant and lower, but “still pretty good” efficacy with South Africa strain. Source